Dalvabancin - Second-Generation Glycopeptide for Serious Gram-Positive Infections

Print

Antibiotics currently used in the treatment of infections due to MRSA.
 
Next»

Return to Profile




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area

For every phase of your drug development